Centerra Gold (CG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
21 Dec, 2025Executive summary
2024 gold production was 368,104 oz and copper production was 54.3M lbs, both near the low end of guidance.
Strong free cash flow was generated, with Mount Milligan and Öksüt as key contributors; Öksüt generated over $480M in free cash flow since its June 2023 restart.
Cash and cash equivalents at year-end were $625M, with total liquidity exceeding $1B.
Nearly $90M was returned to shareholders in 2024 through $44M in buybacks and $44M in dividends.
Strategic progress included the restart of Thompson Creek, ramp-up at Langeloth, and an initial resource at Goldfield, though Goldfield will not proceed to near-term development.
Financial highlights
2024 revenue was $1,214.5M, up 11% year-over-year; Q4 revenue was $302.4M, down 11% from Q4 2023.
2024 net earnings were $80.4M ($0.38/share); adjusted net earnings were $152.9M ($0.72/share).
Q4 2024 net loss was $52.5M, mainly due to a $193.6M non-cash impairment on the Goldfield Project; adjusted Q4 net earnings were $36.6M.
Q4 2024 gold production cost: $1,096/oz; AISC: $1,296/oz; full-year AISC: $1,148/oz.
Ended 2024 with $625M in cash and over $1B in total liquidity.
Outlook and guidance
2025 gold production guidance: 270,000–310,000 oz; copper: 50–60M lbs.
2025 consolidated AISC expected at $1,400–$1,500/oz., up from 2024 due to lower Öksüt production and inflation in Türkiye.
Sustaining capital expenditures for 2025: $97–$120M; non-sustaining: $140–$160M, mainly for Thompson Creek restart.
Langeloth molybdenum roasting expected to increase to 13–15M lbs in 2025, targeting EBITDA-positive results.
Exploration spend in 2025 projected at $35–$45M, focused on Mount Milligan and Kemess.
Latest events from Centerra Gold
- 2025 exceeded production and financial targets, advancing growth and delivering record returns.CG
Q4 202520 Feb 2026 - Strong balance sheet and discounted valuation support organic growth in gold, copper, and molybdenum.CG
Investor presentation20 Feb 2026 - Q2 2024 saw strong results, robust liquidity, and ongoing capital returns with steady guidance.CG
Q2 20242 Feb 2026 - Restart and ramp-up of US molybdenum assets target $472M NPV8% and 22% IRR by 2028.CG
Investor Update20 Jan 2026 - Strong Q3 cash flow, stable costs, and strategic project progress support 2024 targets.CG
Q3 202417 Jan 2026 - All director nominees, auditor appointment, and executive compensation motions were approved.CG
AGM 202525 Nov 2025 - Q1 2025 saw strong cash flow, robust liquidity, and major project advances.CG
Q1 202524 Nov 2025 - Strong Q2 results, robust liquidity, and project advances offset by higher cost guidance.CG
Q2 202523 Nov 2025 - Q3 2025 saw strong free cash flow, project progress, and robust shareholder returns.CG
Q3 202530 Oct 2025